Orasure Technologies, Inc. develops, manufactures, markets and sells oral fluid diagnostic products and specimen collection devices using its own oral fluid technologies, as well as diagnostic products, including immunoassays and other in vitro diagnostic tests and other medical services. The Company’s diagnostic products include tests, which are processed in a laboratory. These products are sold in the United States and internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physician’s offices, and commercial and industrial entities.
Quick Financial Synopsis
BRIEF: For the six months ended 30 June 2009, OraSure Technologies, Inc.'s revenues fell 7% to $34.5M. Net loss totaled $6.8M, up from $242K. Revenues reflect lower sales from cryosurgical systems, substance abuse testing products and licensing & product development revenues. Net loss reflects an increase in general & administrative expenses, higher sales & marketing expenses and the presense of impairment of patent & product rights.
Company Address
OraSure Technologies, Inc.
220 East First Street Bethlehem PA 18015
P: +1610.8821820 F: +1610.8142937